
|Articles|June 29, 2021
The Mainstream Patient: June 29, 2021
Author(s)Morgan Petronelli
This week’s edition of The Mainstream Patient features stories about skin care texture, scalp acne treatments, sanitizing beauty products, jade rollers, plus more.
Advertisement
In this week’s edition, Allure reveals if makeup should be sanitized during the COVID-19 pandemic, and Vogue features a Brooklyn acne clinic who is offering free services to transgender people of color. Also, Harper's Bazaar explains everything there is to know about jade rollers, and InStyle details what makeup application looks like for someone with psoriasis. Finally, Shape explains the importance of skin care texture and the best products to treat scalp acne.
Advertisement
Related to this article

From “Botox in a bottle” to castor oil and face taping, Dermatology Times reviews the evidence behind 3 viral dermatology trends from October.

Dermatology PAs unpack 4 frightening skin care myths and trends, from sunscreen misinformation and citrus DIYs to overusing actives and beef tallow.

The approval expands the IL-23 inhibitor’s indications beyond moderate-to-severe plaque psoriasis to include adults with active psoriatic arthritis.

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of October.

Clinician FAQ on remibrutinib's FDA approval in symptomatic dermographism: RemIND efficacy, mechanism, safety, and supporting CSU evidence.

Elevate-Derm Summer 2026 faculty share practical lessons on hair loss exams, PIH, geriatric dermatology, and managing cholesterol rises on JAK inhibitors.

Atopic dermatitis care is evolving with flexible biologic dosing, expanded pediatric options, and novel oral, topical, and systemic therapies.
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Approves Tildrakizumab for Active Psoriatic Arthritis
2
The Scariest Skin Care Trends Haunting Patients This Halloween
3
October Social Media Mythbusters: 3 Viral Beauty Claims, Debunked
4
Improving Early Identification and Escalation of HS
5


